Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
David J. Margolis, MD, PhD

David J. Margolis, MD, PhD Physician

Director, Cutaneous Ulcer Program
Professor of Dermatology
Professor of Biostatistics and Epidemiology

Dr. Margolis is a Penn Medicine employed physician.

About Dr. David J. Margolis

Recognized by Best Doctors in America 2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012, 2013-2014

Recognized in Philadelphia Magazine's May 2002 Top Docs issue

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties

Specialty:

  • Dermatology

Programs & Centers:

Board Certification:

  • Dermatology, 1991
  • Internal Medicine, 1988

Clinical Expertise:

  • Cellulitis
  • Chronic Wounds
  • Dermato Cellulitis
  • Electric Fields in Wound Healing
  • Facial Lesions
  • Leg Ulcers
  • Precancerous Lesions
  • Pressure Ulcers
  • Pyoderma Gangrenosum
  • Skin Lesion Biopsy
  • Wound Complications

Description of Clinical Expertise

dermatology, chronic wounds

Practice Locations and Appointments

  • Penn Dermatology

    Perelman Center for Advanced Medicine South Pavilion, 1st Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: University of Chicago School of Medicine
Residency: Hospital of the University of Pennsylvania

Memberships

AAMC Forum on Conflict of Interest in Academe (FOCI A), Committee member 2011, National AAMC Forum on Conflict of Interest in Academe (FOCI A), National American Academy of Dermatology and AAD Association Guidelines/Outcomes Task Force (Member, 2001 - 2005), National American Academy of Dermatology, Burden of Disease, workgroup, 2014-, National American Academy of Dermatology, NMSC guideline committee, 2015, National American Academy of Dermatology, Practice Based Data Collection Workshop, 2012 NIH T1D-RAID Special Emphasis Panel, ad hoc 2012, National American College of Epidemiology, National American DermatoEpidemiology Network, National American Dermatology Association,, National American Diabetes Association, (Member, 2000-present), National American Medical Association, (Member, 1981-1993, 2000-present), National Arthritis and Musculoskeletal Skin Diseases Clinical Trials Review Committee (AMSC), ad hoc member, 2016, National British Skin Foundation, International British Skin Foundation, National Chief Scientist Office Experimental and Translational Medicine Research Committee Scotland, International Chief Scientist Office Experimental and Translational Medicine Research Committee Scottland, National Cochrane, Americas Skin Disease Group, National Data Safety and Monitoring Board, ABT 874 Phase III Study, Abbott, National Data Safety and Monitoring Board, ATLAS Phase 4 Study, BiogenIdec, National Data Safety and Monitoring Board, Diabetic Foot Ulcer Study, ApoPharma, National Data Safety and Monitoring Board, IL-12 multiple Phase III studies, Centocor, National Data Safety and Monitoring Board, KAI-Comer Study Phase II, NIAMS, National Data Safety and Monitoring Board, Phase I safety, Zymequest, National Data Safety and Monitoring Board, Twin-Twin Transfusion Study, NIH/NICHD, National Data Safety and Monitoring Board, Venous leg ulcer phase III study, Intercytex, National Data Safety and Monitoring Committee Astellas, Tacrolimus Pediatric study, National Data Safety and Monitoring Committee Astellas, Tacrolimus Pediatric study, National Data Safety and Monitoring Committee Astellas, Tacrolimus Pediatric study, National Data Safety and Monitoring Committee Astellas, Tacrolimus Pediatric study, National Data Safety and Monitoring Committee Centocor, Ustemkinumab, National Data Safety and Monitoring Committee Centocor, Ustemkinumab, National Data Safety and Monitoring Committee Centocor, Ustemkinumab, National Data Safety and Monitoring Committee, CNTO 1275 Centocor, National Data Safety Board, IL-12 Phase II Study, Centocor, National Data Safety Monitoring Committee Clementia, (Chair 2014-present), National Data Safety Monitoring Committee, GSK member 2016, National Data Safety Monitoring Committee, Janssen Guselkumab, (Chair, 2014-present), National Data Safety Monitoring Committee, Regeneron-Sanofi, (Chair, 2015-present), National Data Safety Monitoring Committee, Stiefel (Chair, 2015-present), National Dermatologic Advisory Panel, US Pharmacopeia, National EME (Efficacy and Mechanism Evaluation), Programme review, NHS UK 2016, National European Wound Management Association Editorial Advisor, Position Document on Hard to heal wounds, International European Wound Management Association Editorial Advisor, Position Document on Hard to heal wounds, National FDA Drug Safety and Risk Management Advisory Committee (DSaRM), National FDA Joint Pulmonary-Allergy Drug Advisory Committee, Drug Safety and Risk Management Advisory Committee, and Pediatric Advisory Committee,, National FDA, DODAC committee ad hoc member 2014, National FDA, NDAC committee ad hoc member 2014, National Global Burden of Diseases, Injuries, and Risk Factors Study (GBD Study) Cross-Cutting Issues Expert Group (Core Member) Skin Diseases Expert Group (Core Member), International Global Burden of Diseases, Injuries, and Risk Factors Study (GBD Study): Cross-Cutting Issues Expert Group (Core Member) Skin Diseases Expert Group (Core Member), International International Dermato-epidemiology Association (Member, 1996-present), International Medical Dermatology Society, National Medicare Coverage Advisory Committee (MCAC), Centers for Medicare and Medicaid Services, Department Of Health And Human Services, National National Institute of Health Research, Programme Grants for Applied Researck, UK, National National Institute of Health Research, Programme Grants for Applied Researck, UK, National National Scientific Committee: NIH/NIAMS Scientific Review Committee, Special Emphasis Panel to review MCRC applications, National NGVL (National Gene Vector Laboratories) Scientific Review Board, National NIAD Scientific Review Committee, Special Emphasis Panel, National NIAD Scientific Review Committee,, National NIH MOSS C-02 Special Emphasis Panel, National NIH Study Section to review RFA for Chronic Wounds, National NIH T1D-RAID Special Emphasis Panel, ad hoc, National NIH ZAI 1 PA(J2) 1 Study Section, ad hoc, Chair 2015, National NIH ZDK1 GRB-J J3 Study Section, ad hoc, Chair 2014, National NIH ZDK1 GRB-J J3 Study Section, ad hoc, Chair 2014, National NIH ZDK1 GRB-J J3 Study Section, ad hoc, Chair 2015, National NIH ZNR REV-T (03) Chair, Special Emphasis Panel, National NIH ZNR REV-T, Special Emphasis Panel, National NIH ZNR REV-T, Special Emphasis Panel,, National NIH ZRG1 BCMB-A Special Emphasis Panel, ad hoc 2011, National NIH ZRG1 BCMB-A Special Emphasis Panel, ad hoc 2011, National NIH ZRG1 MOSS T12 Study Section, ad hoc, National NIH ZRG1 MOSS-C (05), ad hoc 2011, National NIH ZRG1 MOSS-U12 Study Section, ad hoc 2015, National NIH ZRG1 SBIB Q11 Study Section, ad hoc, 2013, National NIH ZRG1-MOSS- C05 Special Emphasis Panel, National NIH ZRK1 GRB-1 M7 Study Section, ad hoc, National NIH/NHLBI Gene Therapy Resource Program (GTRP) Scientific Review Board, National NIH/NHLBI Gene Therapy Resource Program Scientific Review Board,, National NIH/NIAMS National Skin Diseases Working Group, National NIH/NIAMS National Skin Diseases Working Group, National NIH/NIAMS Long Range Planning Meeting, National NIH/NIAMS R03 Special Emphasis Panel ZAR1 YZW-E 02 R, National NIH/NIAMS Scientific Review Committee, National Scientific Committees: Special Emphasis Panel to review proposals responding to the Broad Agency Announcement New Research Registries, National NIH/NIAMS Scientific Review Committee, Special Emphasis Panel to review Clinical Trial Planning Grants, National NIH/NIAMS Scientific Review Committee, Special Emphasis Panel to review K23/24 grant applications, National NIH/NIAMS Scientific Review Committee, Special Emphasis Panel to review program project, National NIH/NIAMS Scientific Review Committee, Special Emphasis Panel to Review R01 Applications, National NIH/NIAMS Scientific Review Committee, Special Emphasis Panel to Review R34 Clinical Trial Planning Grant applications, National NIH/NIAMS Scientific Review Committee, Special Emphasis Panel ZRG1 MOSS-K (12) Arthritis, Connective Tissue and Skin Sciences, National NIH/NIAMS Scientific Review Committee, Special Emphasis Panel, AMS 1, National NIH/NIAMS Scientific Review Committee, Special Emphasis Panel, AMS 1,, National NIH/NIAMS Scientific Review Committee, Special Emphasis Panel, ZARI EHB-H C32 Contracts and Proposals, National NIH/NIAMS Skin Diseases Roundtable, National NIH/NIDCR Scientific Review Committee, Special Emphasis Panel to review RFP, National NIH/NIDDK Scientific Review Committee, Special Emphasis Panel, T1D-RAID, National NIH/NIDDK Scientific Review Committee, Special Emphasis Panel,, National NIH/NIOSH Study Section to review RFA for National Occupational Research Agenda, National NIHR Health Technology Assessment Program (UK), International NIHR Health Technology Assessment Programme, National NIHR NCCEME (UK) Trials and Studies Coordinating Centre protocol ad hoc reviewer, International NIHR NCCEME (UK) Trials and Studies Coordinating Centre protocol, National PhD Thesis review University of KwaZulu-Natal, South African, 2015, National Reviewer, NIHR Health Programme Grants Applied research, 2015, National Scientific Advisory Board, APPLES Study, Astellas, National Scientific Advisory Board, Kerecis, 2013, National Self-Assessment Task Force, member, American Academy of Dermatology, National Society for Epidemiologic Research, National Society for Investigative Dermatology and American Academy of Dermatology joint committee on the burden of skin disease (Member, 2004-2005, National Society for Investigative Dermatology, National The American Academy of Dermatology, National The Cochrane Wounds Group, National The Society for Investigative Dermatology, National The Wound Healing Society, National Veterans Administration, VA Scientific Review Committee-HSR&D,, National Worldwide Universities Network (Jane Nixon, University of Leeds, PI) Collaborator, International Worldwide Universities Network (Jane Nixon, University of Leeds, PI), Collaborator, International

Hospital Affiliation

Dr. Margolis is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

epidemiology, clinical trials, pharmacoepidemiology, wound repair, chronic wounds

Selected Publications:

Fett NM, Haynes K, Propert KJ, Margolis DJ.: Predictors of malignancy in patients with chronic pruritus. Journal of Dermatological Science : 2016.

Langan SM, Thomas SL, Smeeth L, Margolis DJ, Nitsch D.: Zoster vaccination is associated with a reduction in zoster in elderly patients with chronic kidney disease. Nephrol Dial Transplant on line : 2016.

Walsh JW, Hoffstad OJ, Sullivan MO, Margolis DJ.: Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabetic Medicine on line : 2016.

Fleming-Dutra KE, Hersh AL, Shapiro DJ, Baroces M, Enns EA, File TM, Finkelstein JA, Gerber JS, Gerber JS, Hyun DY, Linder JA, Lynfield R, Margolis DJ, May LS, Mernstein D, Metlay JP, Newland JG, Piccirillo JF, Roberts RM, Sanchez G, Suda K, Thomas A, Moser T, Zetts RM, Hicks LA.: Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits JAMA 315 ((17)): 1864-1873,,2016.

Cluzet VC, Gerber JS, Metlay JP, Nachamkin I, Zaoutis TE, Davis MF, Julian KG, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Bilker WB, Han X, Mistry RD, Gavin LJ, Tolomeo P, Wise JA, Hu B, Fishman NO, Royer D, Lautenbach E, for the CDC for the CDC Prevention Epicenter Program.: The Effect of Total Household Decolonization on Clearance of Colonization with Methicillin-Resistant Staphylococcus aureus. Infect Control Hosp Epidemiol : 2016.

Fox JD, Baquerizo-Nole KL, Herskovitz I, Freedman JB, Vileikyte L, Margolis DJ, Kirsner RS.: Statins may be associated with six-week diabetic foot ulcer healing Wound Repair Regen, online : 2016.

Mani R, Margolis DJ, Shukla V, Akita S, Lazarides M, Piaggesi A, Falanga V, Teot L, Xie T, Bing FX, Romanelli M, Attinger C, Han CM, Lu S, Meaume S, Xu Z, Viswanathan V.: Optimizing technology use for chronic lower-extremity wound healing: A consensus document. International Lower, Extremty Wounds 15 ((2)): 1-18,2016.

Alavi A, Sibbald RG, Phillips TJ, Miller OF, Margolis DJ, Marston W, Woo K, Romanelli M, Kirsner RS.: What’s new: Management of venous leg ulcers. Part 1. J Amer Acad Dermatology : 2016.

Takeshita, J, Wang S, Shin DB, Mehta NN, Kimmel SE, Margolis DJ, Troxel AB, Gelfand JM: Impact of psoriasis severity on hypertension control: A population-based study in the United Kingdom. JAMA Dermatology. 151 (2): 161-9,2015.

Margolis DJ, Abuabara K, Hoffstad O, Wan J, Raimondo J, Bilker W: No significant association between malignancy and topical use of pimecrolimus. JAMA Dermatology 151 (6): 594-599,2015.

View all publications

Academic Contact Info

901 Blockley Hall
423 Guardian Drive
Department of Dermatology and Department of Biostatistics and Epidemiology
University of Pennsylvania

Philadelphia, PA 19104-4283
Phone: (215) 662-2590
Patient appointments: 800-789-PENN (7366)

Related Links